BioSpace News Archive

Celldex Therapeutics Initiates Phase I Study of New Product Candidate CDX-1140 in Solid Tumors

CDX-1140 is a fully human antibody targeted to CD40, a key activator of immune response that is found on dendritic cells, macrophages and B cells and is also expressed on many cancer cells.

November 30, 2017

·

5 min read

Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR by Par Pharmaceutical

The launch of the 5 and 40 mg strengths complements the 10, 15, 20, 25, 30 and 35 mg strengths of generic Focalin XR previously launched and marketed by Par.

November 30, 2017

·

10 min read

BioCapital

The Alliance for Regenerative Medicine Announces 2018 Cell & Gene Therapies State of the Industry Briefing

The Alliance for Regenerative Medicine announced its 2018 Cell & Gene Therapies State of the Industry briefing will take place January 8, 2018 in San Francisco, held in conjunction with Biotech Showcase™ 2018.

November 30, 2017

·

3 min read

Business

BioTelemetry Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study

The study is expected to discover undiagnosed irregular heart rhythms, such as atrial fibrillation, using the Apple Watch and the dedicated “Apple Heart Study” App.

November 30, 2017

·

1 min read

Business

Acerus Secures CDN$1.6M of New NATESTO Orders from Its U.S. Licensee Aytu Bioscience

As per the terms of the License and Supply Agreement with Aytu, revenues associated with these orders will be recognized on delivery of the product to Aytu, with additional revenues recognized quarterly based on a percentage of net sales.

November 30, 2017

·

7 min read

Nuvo Pharma Announces Normal Course Issuer Bid

The normal course issuer bid will be made in accordance with the requirements of the TSX.

November 30, 2017

·

4 min read

Pharm Country

MonoSol Rx Changes Name to Aquestive Therapeutics and Expands CNS Product Portfolio

The new name reflects the company’s expanded capabilities in developing and commercializing a proprietary portfolio of medicines, initially focused on the CNS.

November 30, 2017

·

2 min read

Pharm Country

Navitas Brings End-to-End R&D Solutions to the Generic Drug Industry

Navitas Life Sciences has conducted more than 1000 projects with over 100 MAH approved in six continents.

November 30, 2017

·

3 min read

Pharm Country

TENA Introduces Incontinence Products With New ConfioAir Breathable Technology to Promote Skin Health

TENA’s ConfioAir technology features a unique outer layer with micro-pores that allows moisture from the inner absorbent core to evaporate.

November 30, 2017

·

3 min read

Deals

SQI Diagnostics Completes Sale of Automated Sqidlite Platform to Predictive Cardiac Customer

SQI Diagnostics today announced it has successfully converted a multi-biomarker cardiac event prediction test from a pioneer in the field of predictive diagnostic medicine, into an SQI-based multiplex test. The test has also been successfully automated on SQI’s “sample-to-answer” sqidlite system.

November 30, 2017

·

3 min read